CDH1致病性变异携带者的结直肠肿瘤: 一项多中心分析
该多中心回顾性分析评估了85例胚系CDH1致病/可能致病性变异携带者的结肠镜结局,平均年龄46.9岁。首次结肠镜发现腺瘤性息肉30例(35.3%),其中进展期腺瘤9例(10.6%)。首次及后续结肠镜均未发现结直肠癌。作者认为CDH1携带者结直肠肿瘤检出率与一般人群相似,尽管胃切除术后可能存在困难,结直肠癌筛查在该人群中仍然重要。
要点
- 85例CDH1致病/可能致病性变异携带者中,首次结肠镜发现腺瘤性息肉30例(35.3%)。
- 其中进展期腺瘤9例(10.6%),首次及后续结肠镜均未检出结直肠癌。
- 作者认为该人群结直肠肿瘤检出率与一般人群相似,结直肠癌筛查仍然重要。
核心结论
- CDH1携带者的结直肠肿瘤检出率与一般人群相似。
- 尽管胃切除术后可能存在困难,结直肠癌筛查在该人群中仍然重要。
研究设计与样本
- 多中心回顾性分析,纳入85例胚系CDH1致病/可能致病性变异携带者,评估结肠镜结局,平均年龄46.9岁。
主要发现
- 首次结肠镜发现腺瘤性息肉30例(35.3%),其中进展期腺瘤9例(10.6%)。
- 首次及后续结肠镜(如有)均未发现结直肠癌。
临床怎么用
- 作者认为尽管胃切除术后可能存在困难,结直肠癌筛查在该人群中仍然重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Germline variants in CDH1 are associated with elevated risks of diffuse gastric cancer and lobular breast cancer. It is uncertain whether there is an increased risk of colorectal neoplasia. METHODS: This was a retrospective analysis of colonoscopy outcomes in patients with germline CDH1 pathogenic/likely pathogenic variants. RESULTS: Eighty-five patients were included with a mean age of 46.9 years. Initial colonoscopy found adenomatous polyps in 30 patients (35.3%), including advanced adenomas in 9 (10.6%). No colorectal cancers were identified on index or subsequent colonoscopies (when available). DISCUSSION: CDH1 carriers have colorectal neoplasia identified at similar rates as in the general population. Despite potential difficulties after gastrectomy, colorectal cancer screening remains important in this population.
引用
- Stanich PP, Elgindi D, Stoffel E, et al. Colorectal Neoplasia in CDH1 Pathogenic Variant Carriers: A Multicenter Analysis. Am J Gastroenterol. 2022. PMID: 36087100. doi:10.14309/ajg.0000000000001996
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。